Autoimmune Hepatitis and Biliary Cholangitis: A Comprehensive Guide for Patients

Last updated 3 August, 2026 | 10:30
Summary

An essential guide to autoimmune hepatitis, PBC, and PSC, offering expert insights, patient-friendly explanations, and practical management advice.

 

Patient education — AIH, PBC and PSC

Autoimmune Hepatitis and Biliary Cholangitis: A Comprehensive Guide for Patients

Autoimmune liver diseases remain unfamiliar to most people despite serious consequences. In these conditions the immune system mistakenly attacks the liver or the bile ducts. This guide explains all three — AIH, PBC and PSC — in language a patient can act on.

Cover of Autoimmune Hepatitis and Biliary Cholangitis: A Comprehensive Guide for Patients by Prof. Seyed-Moayed Alavian and Dr. Seyede Hoda Alavian

Authors

Prof. Seyed-Moayed Alavian, Dr. Seyede Hoda Alavian

Publisher

Brieflands

Publication date

April 6, 2025 (Kindle edition)

Print length

292 pages

Language

English

ISBN-13

978-90-8351-732-2; Iranian record 978-622-87808-0-1

Other edition

Persian edition

Audience

Patients, caregivers, and healthcare professionals

Get the book

Published by Brieflands and available worldwide as a Kindle edition on Amazon. A Persian edition is also available. For institutional orders or translation rights, contact the publisher.

Buy on Amazon →Persian edition

About this book

Among the many conditions affecting people worldwide, autoimmune liver diseases remain relatively unfamiliar to the general public — despite consequences that can be severe. Autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) are chronic disorders in which the immune system mistakenly attacks the liver or the bile ducts, producing inflammation, progressive damage, and, untreated, irreversible liver disease.

They are uncommon relative to other liver diseases, but their impact on patients and families is profound. AIH targets liver cells, causing persistent inflammation that may progress to fibrosis, cirrhosis, and liver failure. PBC affects the small bile ducts within the liver, impairing bile flow and gradually damaging liver tissue. PSC involves inflammation and scarring of both intrahepatic and extrahepatic ducts, narrowing them and raising the risk of serious complications. Advances in medical knowledge, earlier diagnosis, and modern treatment have substantially improved the outlook — which is precisely why timely recognition matters.

Knowledge is among the most powerful tools in managing chronic disease. Understanding causes, symptoms, diagnostic methods, treatment options, and long-term management allows patients, caregivers and clinicians to make informed decisions together. Greater awareness also dispels misconception and encourages people to seek attention before irreversible damage occurs.

This book was written to make complex medical information clear, practical, and accessible. Whether you have been diagnosed with AIH, PBC or PSC, are supporting a family member, or simply want to understand these conditions, it draws on current scientific evidence and clinical experience while keeping the language understandable to readers from any background.

We dedicate this book to everyone living with autoimmune liver diseases, whose courage and resilience continue to inspire advances in research and patient care.From the preface

What the book covers

Autoimmune hepatitis

Persistent inflammation of liver cells, and its progression to fibrosis and cirrhosis.

Primary biliary cholangitis

Damage to the small intrahepatic bile ducts and impaired bile flow.

Primary sclerosing cholangitis

Inflammation and scarring of intrahepatic and extrahepatic ducts.

Diagnosis

How these conditions are recognised, and why early detection changes outcomes.

Treatment

Modern treatment strategies and what they can realistically achieve.

Living with the disease

Long-term management, monitoring, and working with your care team.

Important. The information in this book is for educational purposes. It is designed to increase awareness of autoimmune liver diseases and does not replace professional medical advice, diagnosis, or treatment. Every patient is different; immunosuppressive therapy in particular must be individualised and monitored, and should never be started, adjusted, or stopped except on the advice of a hepatologist familiar with your case.